Supplementary Figure S1 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

<p>Supplementary Figure S1 shows the doubling time of MCF10A-CT, MC26 and M1B26 cell lines in A; the expression of the CD10 mRNA in the METABRIC cohort in B; the probability of survival of patients from the METABRIC cohort in function of CD10 expression in C; the ENI10 score of patients form the METABRIC cohort in D; the relapse-free interval of patients from the METABRIC cohort in function of the ENI10 score in E and the progression free interval in F or overall survival in G of patients form the METABRIC cohort in function of the ENI10 score and of the molecular subtype of the breast tumor.</p>